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Abstract
Background: Since 1900s, visceral leishmaniasis (VL) has been among the most important health problems in
Sudan, particularly in the endemic areas such as eastern and central regions.
Methods: This was a cross sectional, hospital-based study conducted from 1st January 2015 to 31st December 2015
to investigate the epidemiological factors of VL in Gadarif hospital, eastern Sudan.
Results: During the study period there were 47 identified children with VL among 145 suspected cases. The most
common clinical presentations were fever (47, 100%), pallor (47, 100%), weight loss (40, 85.1%), splenomegaly
(37, 78.7%), lymphadenopathy (33, 70.2%), vomiting (32, 68%) cough (28, 59%), loss of appetite (22, 46.8%),
diarrhoea (17, 36.1%) and jaundice (5, 10.6%). With regard to the outcome after short term follow up 37 patients
(78.8%) improved without complications, while 3 (6.4%, 2 (4.3%), 2 (4.3%), 1 (2.1%), 1 (2.1%) and 1 (2.1%) developed
pneumonia, otitis media, septicaemia, urinary tract infection, parasitic infestation and PKDL respectively. Lower
mean of haemoglobin level was observed among the VL cases in comparison with the suspected cases (in whom
VL was excluded) haemoglobin level {8.9 (3.1) Vs 11 (6.3), P = 0.021}. Again more proportion of anaemic (47 (100%)
Vs 14 (14.2%), P = 0.000) and severely anaemic (23 (48.9%) Vs 2 (2%), P = 0.006) patients was detected among the
infected children. Using logistic regression analyses there was significant association between rural residence
(CI = 1.5–24, OR = 19.1, P = 0.023), male gender (CI = 6.6–18.7, OR = 6.4, P = 0.001) and VL among children.
Conclusions: While there is an advance in prevention and management of visceral leishmaniasis our results
indicate that VL is still a public health problem with its severe complications among children in eastern Sudan.
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Background
Visceral leishmaniasis (VL) or kala-azar is a parasitic
infection caused by two leishmanial species, L. donovani
or L. infantum/ chagasi. The infection is transmitted by
the bite of infected sand fly Phlebotomus argentipes. L.
infantum/ chagasi infects mostly children and immune-
suppressed individuals, whereas L. donovani infects all
age groups [1]. Anaemia, weight loss, hepatosplenome-
galy, lymphadenopathy, prolonged fever, anorexia, loss of
appetite, pancytopenia and hair changes are the most
common clinical presentation among the children [2].
Bacterial super-infection such as pneumonia, septicemia,
otitis media, urinary tract infections and skin infections
are the major complications leading to death in children
with VL [3]. Other complications among children
include parasitic infestations of the alimentary tract and
post-kala-azar dermal leishmaniasis (PKDL) [1]. World-
wide the annual incidence and prevalence of kala-azar
cases are 0.5 and 2.5 million, respectively [1]. According
to recent reports, leishmaniasis is endemic in 98 coun-
tries, and around 1.3 million new cases are reported
every year, with an estimated 20,000 to 40,000 deaths
every year [4]. The vast majority (more than 90%) of
cases are in Sudan, India, Bangladesh, Nepal and Brazil.
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Children constitute 7-10% of such cases in the endemic
regions [5]. Since 1900s, visceral leishmaniasis (VL) has
been among the most important health problems in
Sudan, particularly in the endemic areas such as eastern
and central regions [6]. Thus, the current study was
conducted to investigate the epidemiological factors of
VL among children in Gadarif, eastern Sudan and the
results of this study is expected to provide the health
planners with fundamental data necessary for the imple-
mentation of preventive measures in this area of the
country.
Methods
Study design and data collection
This was a cross sectional, hospital-based study con-
ducted from 1st January 2015 to 31st December 2015 to
investigate the epidemiological factors of VL in Gadarif
hospital, eastern Sudan.
The cases included all children ≤14 year old with clinical
symptoms of VL and in whom the diagnosis of VL was
confirmed by laboratory test. A structured questionnaire
was used to gather the socio-demographic characteristics
(age, residence, the education and occupation of both par-
ents), duration of the illness, reason of clinical presentation
(fever, fatigue, weakness, loss of appetite and weight loss),
clinical sign (pallor, jaundice, epistaxis or sign of bleeding
tendency, mucocutanous lesion, PKDL, enlarged lymph
nodes, spleen and liver), super-infection (pneumonia, otitis
media, septicaemia, worm infestation) and patient outcome
(improvement, death). Proper systemic examination was
performed to each patient by a paediatrician including car-
diovascular system, respiratory system, abdomen, musculo-
skeletal system and central nervous system. Basic tests were
performed for every patient on admission and repeated
when clinically indicated. These included complete blood
count, urine analysis, blood film for malaria, stool analysis
and abdominal ultrasound. We looked for the parasite in
bone marrow aspirate and other tissues using Giemsa-stain.
The diagnosis was confirmed by the visualization of the
amastigote form of the parasite by microscopic examination
of aspirates from lymph nodes or bone marrow. Specific
anti-leishmanial drugs (sodium stibogluconate was the first
line while in cases with severe side effects liposomal
amphotericine B was the second option) and the aggressive
management of any concomitant bacterial or parasitic in-
fections, anaemia, hypovolemia (decreased blood volume)
and malnutrition was the treatment for the patients. All pa-
tients were under multidisciplinary care and were closely
followed during their hospital stay and then every month in
the refer clinic.
Statistics
Data was entered into a computer database and SPSS
software (SPSS Inc., Chicago, IL, USA, version 16.0) and
double checked before analysis. Analysis of variance was
used to compare means and x2 was used for categorical
variables. Univariate and multivariate analyses were
performed. Visceral leishmaniasis was the dependent
variable and socio-demographic characteristics were
independent variables. Confidence intervals of 95% were
calculated and P < 0.05 was considered significant.
Results
During the study period there were 47 identified
children with VL among 145 suspected cases. All the
studied patients were residents of Gadarif State, their
age ranged between 0 and 12 year, and the vast majority
of the infected children were of rural residence (28/47,
59.6%). The age distribution of the studied cases was as
follows: infants (0 to 2 years) constituted 7 (14.9%) cases;
toddlers (3 to 5 years) 17 (36.2%) cases; children (6 to
9 years) 16 (34%) cases and ten- to twelve-year-old con-
stituted 7 (14.9%) of the cases. Out of the total 34
(72.3%) were male and 13 (27.7%) were female giving
2.6:1 male: female ratio. The most common clinical pre-
sentations were fever (47, 100%), pallor (47, 100%),
weight loss (40, 85.1%), splenomegaly (37, 78.7%),
lymphadenopathy (33, 70.2%), vomiting (32, 68%) cough
(28, 59%), loss of appetite (22, 46.8%), diarrhoea (17,
36.1%) and jaundice (5, 10.6%). A positive family history
for leishmaniasis was seen in (9) 19.1% of the cases. An-
aemia (haemoglobin level < 12 g/dl) was detected in all
(100%) patients and severe anaemia (haemoglobin level
< 7 g/dl) was reported among 23 (48.9%) cases. Severe
anaemia was observed in 4, 5, 8 and 6 cases of infant,
toddlers, children and ten to twelve year old groups
respectively. Interestingly 25.5% (12/47) were initially
misdiagnosed and mistreated as cases of febrile illness
such as malaria and other. Most of the patients 41
(87.2%) responded to sodium stibogluconate, in 6
patients (12.8%) sodium stibogluconate was stopped due
to toxic effects. These patients received libosomal
amphotericin B and showed good response. With regard
to the outcome after short term follow up 37 patients
(78.8%) improved without complications, while 3 (6.4%),
2 (4.3%), 2 (4.3%), 1 (2.1%), 1 (2.1%) and 1 (2.1%) devel-
oped pneumonia, otitis media, septicaemia, urinary tract
infection, parasitic infestation and PKDL respectively.
Lower mean of haemoglobin level was observed among
the VL cases in comparison with the suspected cases (in
whom VL was excluded), (Table 1). Again more propor-
tion of anaemic (47 (100%) Vs 14 (14.2%), P = 0.000) and
severely anaemic (23 (48.9%) Vs 2 (2%), P = 0.006)
patients was detected among the infected children,
(Table 1). Using logistic regression analyses there was
significant association between rural residence (CI = 1.5–
24, OR = 19.1, P = 0.023), male gender (CI = 6.6–18.7,
OR = 6.4, P = 0.001) and VL among children, (Table 2).
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Discussion
This is the first published data on VL among children in
Gadarif, eastern Sudan which is populated by 1,7 million
inhabitants. The current study showed significant associ-
ation between residence, male gender and VL among
children and nearly one half (48.9%) of VL patients had
severe anaemia.. Severe VL epidemics are reported in
poor communities and poor people in developing and
middle income countries such as Nepal and India [7].
Anaemia is a common public health problem in eastern
Sudan where 36.2% of the adults had anaemia [8]; the
common causes of anaemia in this area include: chronic
illness, followed by nutritional and repeated malaria in-
fection [9]. Severe VL epidemics have been reported in
the past: in Southern Sudan, in a context of civil war
and at that time VL killed an estimated 100,000 people
out of a population of 280,000 between 1984 and 1994
[10]. Rapid urbanization, and human migration are
known risk factors that potentiate the spread of the dis-
ease. Gadarif state is bordering two neighbouring coun-
tries (Ethiopia and Eretria) and characterized by poverty
with nomads and refugees and this might explain the
prevalence of the infection in this area of Sudan. Inter-
estingly 25.8% of the patients were initially misdiagnosed
and mistreated as cases of febrile illness such as malaria.
This is attributed to the lack of proper diagnostic facil-
ities and low priority of leishmaniasis in our setting. Fur-
thermore this may be another problem added to the
probability of relapses due to loss of follow up and clin-
ical complications. Thus health care providers generally
need high clinical suspicion to diagnose VL. The clinical
presentation of VL in children in the majority of the
cases is more severe than in adults, commonly with se-
vere anaemia. In our cases, fever and pallor, weight loss
and lymphadenopathy were the most common clinical
presentations. The clinical presentation of VL is similar
in the various endemic areas. However lymphadenop-
athy is rarely found in Indian VL patients but it is fre-
quent in Sudanese VL patients [11]. In a study
conducted by Rai et al., majority of the patients (98%)
presented with fever followed by abdominal distension
(47%), pallor (44%), weight loss (43%), diarrhoea (17%),
vomiting (15%) and hepatosplenomegaly (83%) [12].
Again and in consistent with our results, weight loss,
hepatosplenomegaly, lymphadenopathy and prolonged
fever were the most common clinical signs reported by
Walyeldin and his colleagues in Omdurman Emergency
Hospital for Children (OEHC), Sudan, 2006–2008 [6].
The severity of anaemia in children with VL in this study
is also seen in other studies [13]. Alvar J et al. also men-
tioned that children with VL suffer more severe anaemia
than adults [14]. In our study anaemia was seen in all
patients while severe anaemia was reported in 23 cases
which is in line with studies conducted in Kashmir and
Peshawar where anaemia was seen in all (100%) cases of
VL [15, 16]. The reported complications of VL among
our investigated children in this study include: pneumo-
nia, otitis media, septicaemia, urinary tract infection,
parasitic infestation and PKDL. While PKDL is not rare
in Sudanese VL patients, liver impairment and jaundice
are a rare finding [13]. Complications in eyes and mu-
cous membranes were seen but rare. The interval
between treated VL and PKDL is 0–6 months in Sudan
and 6 months to 3 years in India [17]. In this study 85%
respond to sodium stibogluconate (Pentostam ®) which
is not different from studies in other areas, for example
studies conducted by Kirk and Satti early in 1940 [18]
and Khalil et al. in 1998 [19]. In agreement with our
study Ali Shah et al. in Peshawar [16] and a study from
Muzaffarabad [20] showed a male to female ratio of 2:1.
However in contrast to our study Qasmi et al., in
Morocco, reported a higher mean age and a female pre-
dominance in children with leishmaniasis [20]. Male pre-
dominance in our study could be easily justified by the
fact that the male children usually work with their
fathers in the farms and thus there is greater chance to
be exposed to the sand fly. In our study there was sig-
nificant correlation between VL and rural residence.
Table 1 Comparison between children with VL and those






Age, years 5.1 (3.3) 4.8 (3.1) 0.313
Weight 10.6 (5) 10.6 (4.9) 0.529
Hb, gm\dl 8.9 (3.1) 11 (6.3) 0.021
Rural residence 28 (59.6) 21 (21.4) 0.000
Gender. male 34 (72.3) 29 (29.6) 0.002
Family history, yes 9 (19.1) 24 (24.5) 0.310
Anaemia , yes 47 (100) 14 (14.2) 0.000
Severe anaemia, yes 23 (48.9) 2 (2) 0.006
Data of age, weight and Hb are shown as mean (SD) while data of other
variables are shown as number (%) as applicable
Table 2 Factors associated with VL among children in Gadarif
hospital, eastern Sudan, using univariate and multivariate
analyses
Variable Univariate analyses Multivariate analyses
OR 95% CI P-value OR 95% CI P-value
Age, year 0.9 0.8–1.0 0.167 0.9 0.4–1.9 0.957
Residence, rural 5.0 2.5–11.5 0.000 19.1 1.5–24 0. 023
Weight, Kg 0.6 1.0–2.0 0.409 0.9 0.8–1.0 0.081
Gender, male 6.2 2.8–13.4 0.000 6.4 6.6–18.7 0.001
Family history, yes 0.7 0.3–1.7 0.474 0.8 0.8–1.9 0.677
Anaemia, yes 45 14–146 0.000 47 3–60.4 0.003
Abbreviations: OR odds ratio, CI confidence interval
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Visceral leishmaniasis affects poor communities, gener-
ally in remote rural areas. Patients and families affected
by VL become poorer because of the high direct costs
(for example, the costs of VL diagnosis and treatment)
and indirect costs (for example, loss of household
income) of the disease [7, 21].
Conclusions
While there is an advance in prevention and manage-
ment of visceral leishmaniasis our results indicate that
VL is still a public health problem with its severe com-
plications among children in eastern Sudan. High clin-
ical suspicion and introducing the preventive measures
(prevention of transmission through vector control and
community awareness) are needed to reduce the spread
of the infection.
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